#64Global 2000
Prev
 / 
Next

Forbes does not accept payment for placement on lists.

From the Editor
CVS Health Corp. engages in the provision of health care services. It operates through the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits, and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioural health, medical management capabili... Read More
CVS Health Company Stats
Industry
Healthcare & Social Services
Founded
1963
Headquarters
Woonsocket, Rhode Island
Country/Territory
United States
Chief Executive Officer
Karen S. Lynch
Employees
300,000

Forbes Lists

America's Best Employers By State (2024)
#64
Global 2000 (2024)
#290
Best Brands For Social Impact (2024)
#270
Best Customer Service (2024)
#32
Green Growth Companies (2021)
#87
Just Companies (2021)
#55
World's Most Valuable Brands (2020)
Blockchain 50 (2019)
#27
America's Largest Public Companies (2018)
#217
Top Regarded Companies (2017)

CVS Health Financial Summary

Select list year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Revenue
$361.3B
Assets
$249.7B
Profits
$7.3B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
CVS Health (CVS) Stock Price Performance
CVS Health (CVS) Stock Key Data
SummaryAdditional DataAnalystsHistorical Quotes

Key Data

Previous Close
53.19
Open
53.73
Day’s Range
53.45 x 56.78
Volume
18,036,801
52 Week Range
52.71 x 83.25

Market Cap
$66.93B
P/E Ratio (ttm)
13.45
Forward P/E
8.83
Diluted EPS (ttm)
3.95
Dividends Per Share
2.60
Dividend Yield
5.00%
Ex-Dividend Date
Oct 21, 2024

Valuation Measures

P/E Ratio (ttm)
13.45
Forward P/E
8.83
Price to Sales (ttm)
0.18
Price to Book Value (ttm)
0.89
Price to Tangible Book Value (ttm)
N/A
Total Enterprise Value to EBIT (ttm)
14.70
Total Enterprise Value to EBITDA (ttm)
8.14
Total Enterprise Value to Total Revenue (ttm)
0.38
Markets data provided by S&P and by Xignite

Profitability Metrics

Gross Margin (ttm)
13.81%
Operating Margin (ttm)
2.60%
Net Margin (ttm)
1.37%
Return on Assets (ttm)
2.37%
Return on Equity (ttm)
6.70%

Revenue and Earnings Metrics

Revenue (ttm)
$367.25B
Revenue Per Share (ttm)
290.20
Revenue Growth (y/o/y)
5.96%
EBITDA (ttm)
$14.12B
EBITDA Growth (y/o/y)
-24.48%
Diluted EPS (ttm)
3.95
Diluted EPS Growth (y/o/y)
-40.58

Cash and Debt Metrics

Total Cash
$9.68B
Total Cash Per Share
5.47
Total Debt
$82.7B
Total Debt/Equity
110.12%
Current Ratio
0.80
All values as of most recently reported quarter unless otherwise noted.
Markets data provided by S&P and by Xignite
Consensus Recommendation
Outperform
Consensus Price
68.50
Range of Price Targets
58.00 to 93.00
Range of EPS
4.49 to 7.69
Consensus EPS
6.02
Consensus Revenue
$386.12B
Range of Revenue
$375.29B to $398.12B
  • Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months.
  • EPS and Revenue estimates are for the next 12 months.
Markets data provided by S&P and by Xignite
DATEOPENHIGHLOWCLOSEADJUSTED CLOSEVOLUME
Nov 15, 202454.9955.0652.7153.1953.1916,695,415
Nov 14, 202454.0255.1953.8655.0955.09879,226
Nov 13, 202453.8954.6353.6854.2754.278,050,715
Nov 12, 202455.6255.6253.5154.0354.031,597,033
Nov 11, 202455.5856.4355.1655.8155.8111,570,603
Nov 8, 202457.1957.2855.4555.5455.5413,650,265
Nov 7, 202461.2961.6957.0657.0757.0722,292,314
Nov 6, 202461.7063.3360.8261.6161.6129,141,144
Nov 5, 202454.5055.3554.3155.3455.3411,114,958
Nov 4, 202455.9756.6554.6554.6554.6511,544,198
Markets data provided by S&P and by Xignite
Related People & Companies
Karen Lynch
Karen Lynch
Employed by Company
View Profile
Elevance Health
Elevance Health
Related by Industry: Healthcare & Social Services
View Profile
Brown University
Brown University
Located in Providence-New Bedford-Fall River, RI-MA
View Profile

More on Forbes

also on forbes

How Elon Musk Could Benefit From Trump’s FCC Nominee Brendan Carr
Dallas Wings Get Top Pick In 2025 WNBA Draft As Draft Lottery Winners
Post Election, X Rival Bluesky Is Adding Millions Of Users